A new—and costly—category of weight loss drugs has burst into the market, targeting the nearly 40% of the world’s population who are overweight or obese. Considered by some experts to be a game changer in obesity, GLP-1 (glucagon-like peptide-1) receptor agonists are in such high demand that some people with diabetes (the original indication) are […]
Articles
HPA (China) News – October 2023
At this exhibition, DSM-Firmenich will focus on intestinal health and showcase its intestinal health portfolio, including post-biological agents, human milk oligosaccharide (HMO) ingredients, probiotics and enzymes. In addition, DSM-Firmich will launch a “proprietary strain portfolio” called Humiome PostLB, which includes fermented L.fermentum and L.delbrueckii. It is reported that this ingredient is manufactured using Adare Biome’s […]
Obesity and the Gut Microbiome: Current Insights
Obesity has reached epidemic levels, leading to a global crisis characterized by myriad health issues, premature mortality, and significant economic burdens. The historical approach to weight loss has been fraught with challenges. While lifestyle changes, drugs, and surgery are options that can be effective in the short term, many people fail to keep the weight […]
Probiota Global 2024
Probiota was once again the sold-out, microbiome event of the year in 2023! Brought to you by NutraIngredients, Probiota returns from 7 to 9 February 2024 in Milan, Italy and is now open for delegate bookings. The key themes running through the event will include Gut-liver axis, Marketing insights, Personalisation, Improving skin health, Innovation with next-gen and Regulatory developments, […]
Supply Side West 2023
What an incredible week it was at Supply Side West 2023! The IPA has revealed its new look as we have rebranded to include our new scope. We also hosted our annual General Assembly, to network with our members and discuss our plans for 2024. It was an absolute pleasure spending time with our valued members. […]
IPA Statement Concerning Tragic Death of a Premature Infant who received a Probiotic Product.
As you may already know, there has been a statement issued by the FDA as a warning regarding the use of probiotics in premature infants. Our critical response team was activated immediately at the beginning of October. The team analyzed the situation and determined that at the time, there was not enough information to comment […]